Futura Medical Regulatory News (FUM)

31 Jan 2007 08:00

Futura Medical PLC31 January 2007 For immediate release 31 January 2007 Futura Medical Plc Additional Listing Futura Medical plc (the "Company"), the AIM-listed pharmaceutical group thatdevelops innovative products for consumer healthcare with expertise in sexualhealth, has applied for 50,000 new ordinary shares of 0.2p each in the Companyto be admitted to trading on the AIM market of the London Stock Exchange. Theshares are being issued following the exercise of options. The shares will rank pari passu with existing ordinary shares and dealings areexpected to commence in the new ordinary shares at 8.00am on 5 February 2007.Pursuant to AIM Notice 26, the Company's total issued share capital followingthe anticipated admission of the shares as set out above is 55,353,601. For further information:Futura Medical plc www.futuramedical.co.ukJames Barder, Chief Executive Tel: +44 (0) 1483 685 670mail to: james.barder@futuramedical.co.uk Media enquiries:Buchanan CommunicationsMark Court Tel: +44 (0) 020 7466 5000mail to: markc@buchanan.uk.comRebecca Skye Dietrichmail to: rebeccad@buchanan.uk.com This information is provided by RNS The company news service from the London Stock Exchange